Concepedia

Publication | Open Access

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

46

Citations

21

References

2013

Year

Abstract

In compensated patients with advanced fibrosis due to HCV-1, triple therapy with TVR led to satisfactory rates of safety, tolerability and on-treatment virological response with adequate managements of AEs.

References

YearCitations

Page 1